{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T14:53:10Z","timestamp":1763563990597},"publisher-location":"New York, NY","reference-count":39,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493985661"},{"type":"electronic","value":"9781493985678"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-1-4939-8567-8_18","type":"book-chapter","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T14:31:47Z","timestamp":1530196307000},"page":"197-219","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Utilization of Feline ELISpot to Evaluate the Immunogenicity of a T Cell-Based FIV MAP Vaccine"],"prefix":"10.1007","author":[{"given":"Bikash","family":"Sahay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alek M.","family":"Aranyos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"McAvoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet K.","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,29]]},"reference":[{"key":"18_CR1","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","volume":"361","author":"S Rerks-Ngarm","year":"2009","unstructured":"Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R et al (2009) Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 361:2209\u20132220","journal-title":"N Engl J Med"},{"key":"18_CR2","doi-asserted-by":"publisher","first-page":"10004","DOI":"10.1128\/JVI.00359-13","volume":"87","author":"MP Sanou","year":"2013","unstructured":"Sanou MP, Roff SR, Mennella A, Sleasman JW, Rathore MH, Yamamoto JK et al (2013) Evolutionarily conserved epitopes on human immunodeficiency virus type 1 (HIV-1) and feline immunodeficiency virus reverse transcriptases detected by HIV-1-infected subjects. J Virol 87:10004\u201310015","journal-title":"J Virol"},{"key":"18_CR3","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1080\/21645515.2015.1026500","volume":"11","author":"SR Roff","year":"2015","unstructured":"Roff SR, Sanou MP, Rathore MH, Levy JA, Yamamoto JK (2015) Conserved epitopes on HIV-1, FIV and SIV p24 proteins are recognized by HIV-1 infected subjects. Hum Vaccin Immunother 11:1540\u20131556","journal-title":"Hum Vaccin Immunother"},{"key":"18_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.vetimm.2008.01.030","volume":"123","author":"EW Uhl","year":"2008","unstructured":"Uhl EW, Martin M, Coleman JK, Yamamoto JK (2008) Advances in FIV vaccine technology. Vet Immunol Immunopathol 123:65\u201380","journal-title":"Vet Immunol Immunopathol"},{"key":"18_CR5","first-page":"51","volume-title":"Cellular and molecular immunology","author":"AK Abbas","year":"2015","unstructured":"Abbas AK, Lichtman AH, Pillai S (2015) Cellular and molecular immunology, 8th edn. Elsevier, Philadelphia, PA, pp 51\u201384. 199\u2013229, 231-238, 493-501.","edition":"8"},{"key":"18_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0065-2776(07)96002-2","volume":"96","author":"JR Schoenborn","year":"2007","unstructured":"Schoenborn JR, Wilson CB (2007) Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 96:41\u2013101","journal-title":"Adv Immunol"},{"key":"18_CR7","first-page":"113","volume-title":"Cytokine reference, Volume 1: Ligands","author":"KA Smith","year":"2001","unstructured":"Smith KA (2001) IL-2. In: Oppenheim J, Feldmann M (eds) Cytokine reference, Volume 1: Ligands. Academic Press, San Diego, CA, pp 113\u2013125"},{"key":"18_CR8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/302305a0","volume":"302","author":"T Taniguchi","year":"1983","unstructured":"Taniguchi T, Matsui H, Fujita T, Takaoka C, Kashima N, Yoshimoto R et al (1983) Structure and expression of a cloned cDNA for human interleukin-2. Nature 302:305\u2013310","journal-title":"Nature"},{"key":"18_CR9","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1006\/cyto.1995.0098","volume":"7","author":"E Hagiwara","year":"1995","unstructured":"Hagiwara E, Abbasi F, Mor G, Ishigatsubo Y, Klinman DM (1995) Phenotype and frequency of cells secreting IL-2, IL-4, IL-6, IL-10, IFN and TNF-alpha in human peripheral blood. Cytokine 7:815\u2013822","journal-title":"Cytokine"},{"key":"18_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1189\/jlb.0806521","volume":"82","author":"L Barrett","year":"2007","unstructured":"Barrett L, Dai C, Gamberg J, Gallant M, Grant M (2007) Circulating CD14-CD36+ peripheral blood mononuclear cells constitutively produce interleukin-10. J Leukoc Biol 82:52\u2013160. (Note that CD14-CD36+ PBMC is considered to be macrophages and monocytes [5].).","journal-title":"J Leukoc Biol"},{"key":"18_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/978-94-024-0921-5_5","volume":"941","author":"S Rutz","year":"2016","unstructured":"Rutz S, Ouyang W (2016) Regulation of interleukin-10 expression. Adv Exp Med Biol 941:89\u2013116","journal-title":"Adv Exp Med Biol"},{"key":"18_CR12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cytogfr.2010.09.002","volume":"21","author":"R Sabat","year":"2010","unstructured":"Sabat R, Gr\u00fctz G, Warszawska K, Kirsch S, Witte E, Wolk K et al (2010) Biology of interleukin-10. Cytokine Growth Factor Rev 21:331\u2013344","journal-title":"Cytokine Growth Factor Rev"},{"issue":"Suppl. 3","key":"18_CR13","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/S0264-410X(02)00164-0","volume":"20","author":"RL Hunter","year":"2002","unstructured":"Hunter RL (2002) Overview of vaccine adjuvants: present and future. Vaccine 20(Suppl. 3):S7\u2013S12","journal-title":"Vaccine"},{"key":"18_CR14","first-page":"731","volume":"69","author":"A Go\u0142o\u015b","year":"2015","unstructured":"Go\u0142o\u015b A, Luty\u0144ska A (2015) Aluminium-adjuvanted vaccines--a review of the current state of knowledge. Przegl Epidemiol 69:731\u2013734. 871-874.","journal-title":"Przegl Epidemiol"},{"key":"18_CR15","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","volume":"372","author":"SP Buchbinder","year":"2008","unstructured":"Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D et al (2008) Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372:1881\u20131893","journal-title":"Lancet"},{"key":"18_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-1-61779-325-7_4","volume":"792","author":"JR Abbott","year":"2012","unstructured":"Abbott JR, Pu R, Coleman JK, Yamamoto JK (2012) Utilization of feline ELISPOT for mapping vaccine epitopes. Methods Mol Biol 792:47\u201363","journal-title":"Methods Mol Biol"},{"key":"18_CR17","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1128\/JVI.77.3.2081-2092.2003","volume":"77","author":"MM Addo","year":"2003","unstructured":"Addo MM, Yu XG, Rathod A, Cohen D, Eldridge RL, Strick D et al (2003) Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol 77:2081\u20132092","journal-title":"J Virol"},{"key":"18_CR18","doi-asserted-by":"publisher","first-page":"9210","DOI":"10.1128\/JVI.75.19.9210-9228.2001","volume":"75","author":"V Novitsky","year":"2001","unstructured":"Novitsky V, Rybak N, McLane MF, Gilbert P, Chigwedere P, Klein I et al (2001) Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design. J Virol 75:9210\u20139228","journal-title":"J Virol"},{"key":"18_CR19","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1097\/01.aids.0000131320.75396.4d","volume":"18","author":"J Lieberman","year":"2004","unstructured":"Lieberman J (2004) Tracking the killers: how should we measure CD8 T cells in HIV infection? AIDS 18:1489\u20131493","journal-title":"AIDS"},{"key":"18_CR20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nprot.2009.7","volume":"4","author":"H Streeck","year":"2009","unstructured":"Streeck H, Frahm N, Walker BD (2009) The role of IFN-gamma Elispot assay in HIV vaccine research. Nat Protoc 4:461\u2013469","journal-title":"Nat Protoc"},{"key":"18_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1089\/aid.2007.0125","volume":"24","author":"S Kuerten","year":"2008","unstructured":"Kuerten S, Nowacki TM, Kleen TO, Asaad RJ, Lehmann PV, Tary-Lehmann M (2008) Dissociated production of perforin, granzyme B, and IFN-gamma by HIV-specific CD8(+) cells in HIV infection. AIDS Res Hum Retroviruses 24:62\u201371","journal-title":"AIDS Res Hum Retroviruses"},{"key":"18_CR22","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003165","volume":"4","author":"DZ Soghoian","year":"2012","unstructured":"Soghoian DZ, Jessen H, Flanders M, Sierra-Davidson K, Cutler S, Pertel T et al (2012) HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome. Sci Transl Med 4:123ra25","journal-title":"Sci Transl Med"},{"key":"18_CR23","doi-asserted-by":"publisher","first-page":"5166","DOI":"10.4049\/jimmunol.1102756","volume":"188","author":"MS Souza de","year":"2012","unstructured":"de Souza MS, Ratto-Kim S, Chuenarom W, Schuetz A, Chantakulkij S, Nuntapinit B et al (2012) The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope. J Immunol 188:5166\u20135176","journal-title":"J Immunol"},{"key":"18_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00281-006-0025-4","volume":"28","author":"G Makedonas","year":"2006","unstructured":"Makedonas G, Betts MR (2006) Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection. Springer Semin Immunopathol 28:209\u2013219","journal-title":"Springer Semin Immunopathol"},{"key":"18_CR25","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.vaccine.2016.01.017","volume":"34","author":"AM Aranyos","year":"2016","unstructured":"Aranyos AM, Roff SR, Pu R, Owen JL, Coleman JK, Yamamoto JK (2016) An initial examination of the potential role of T-cell immunity in protection against feline immunodeficiency virus (FIV) infection. Vaccine 34:1480\u20131488","journal-title":"Vaccine"},{"key":"18_CR26","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.tips.2009.09.005","volume":"30","author":"KA O\u2019Connell","year":"2009","unstructured":"O\u2019Connell KA, Bailey JR, Blankson JN (2009) Elucidating the elite: mechanisms of control in HIV-1 infection. Trends Pharmacol Sci 30:631\u2013637","journal-title":"Trends Pharmacol Sci"},{"key":"18_CR27","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/QAD.0b013e3283377a1e","volume":"24","author":"RE Owen","year":"2010","unstructured":"Owen RE, Heitman JW, Hirschkorn DF, Lanteri MC, Biswas HH, Martin JN et al (2010) HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses. AIDS 24:1095\u20131105","journal-title":"AIDS"},{"key":"18_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/science.1237874","volume":"340","author":"SG Hansen","year":"2013","unstructured":"Hansen SG, Sacha JB, Hughes CM, Ford JC, Burwitz BJ, Scholz I et al (2013) Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms. Science 340:1237874","journal-title":"Science"},{"key":"18_CR29","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0165-2427(02)00227-1","volume":"90","author":"EW Uhl","year":"2002","unstructured":"Uhl EW, Heaton-Jones TG, Pu R, Yamamoto JK (2002) FIV vaccine development and its importance to veterinary and human medicine: a review FIV vaccine 2002 update and review. Vet Immunol Immunopathol 90:113\u2013132","journal-title":"Vet Immunol Immunopathol"},{"key":"18_CR30","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.vaccine.2004.05.032","volume":"23","author":"M Omori","year":"2004","unstructured":"Omori M, Pu R, Tanabe T, Hou W, Coleman JK, Arai M et al (2004) Cellular immune responses to feline immunodeficiency virus (FIV) induced by dual-subtype FIV vaccine. Vaccine 23:386\u2013398","journal-title":"Vaccine"},{"key":"18_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052940","volume":"8","author":"J Zhang","year":"2013","unstructured":"Zhang J, Yang JM, Wang HJ, Ru GQ, Fan DM (2013) Synthesized multiple antigenic polypeptide vaccine based on B-cell epitopes of human heparanase could elicit a potent antimetastatic effect on human hepatocellular carcinoma in vivo. PLoS One 8:e52940","journal-title":"PLoS One"},{"key":"18_CR32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/1743-422X-7-151","volume":"7","author":"G Zhao","year":"2010","unstructured":"Zhao G, Sun S, Du L, Xiao W, Ru Z, Kou Z et al (2010) An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus. Virol J 7:151","journal-title":"Virol J"},{"key":"18_CR33","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1089\/vim.2007.0029","volume":"20","author":"G Amexis","year":"2007","unstructured":"Amexis G, Young NS (2007) Multiple antigenic peptides as vaccine platform for the induction of humoral responses against dengue-2 virus. Viral Immunol 20:657\u2013663","journal-title":"Viral Immunol"},{"key":"18_CR34","first-page":"783","volume":"48","author":"M M\u00e4gerlein","year":"1998","unstructured":"M\u00e4gerlein M, Hock D, Adermann K, Neidlein R, Forssmann WG, Strein K (1998) Production of sequence specific polyclonal antibodies to human parathyroid hormone 1-37 by immunization with multiple antigenic peptides. Arzneimittelforschung 48:783\u2013787","journal-title":"Arzneimittelforschung"},{"key":"18_CR35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/(SICI)1099-1387(200005)6:5<217::AID-PSC242>3.0.CO;2-U","volume":"6","author":"LJ Cruz","year":"2000","unstructured":"Cruz LJ, Quintana D, Iglesias E, Garcia Y, Huerta V, Garay HE et al (2000) Immunogenicity comparison of a multi-antigenic peptide bearing V3 sequences of the human immunodeficiency virus type 1 with TAB9 protein in mice. J Pept Sci 6:217\u2013224","journal-title":"J Pept Sci"},{"key":"18_CR36","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00262-016-1840-7","volume":"65","author":"I Moldovan","year":"2016","unstructured":"Moldovan I, Targoni O, Zhang W, Sundararaman S, Lehmann PV (2016) How frequently are predicted peptides actually recognized by CD8 cells? Cancer Immunol Immunother 65:847\u2013855","journal-title":"Cancer Immunol Immunother"},{"key":"18_CR37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.rvsc.2017.05.003","volume":"115","author":"J Wessely-Szponder","year":"2017","unstructured":"Wessely-Szponder J, Szponder T, Bobowiec R (2017) Different activation of monocyte-derived macrophages by antimicrobial peptides at a titanium tibial implantation in rabbits. Res Vet Sci 115:201\u2013210","journal-title":"Res Vet Sci"},{"key":"18_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.biochi.2013.12.022","volume":"101","author":"JM Pantic","year":"2014","unstructured":"Pantic JM, Mechkarska M, Lukic ML, Conlon JM (2014) Effects of tigerinin peptides on cytokine production by mouse peritoneal macrophages and spleen cells and by human peripheral blood mononuclear cells. Biochimie 101:83\u201392","journal-title":"Biochimie"},{"key":"18_CR39","doi-asserted-by":"publisher","first-page":"4566","DOI":"10.1128\/AAC.00742-13","volume":"57","author":"M Bangert","year":"2013","unstructured":"Bangert M, Wright AK, Rylance J, Kelly MJ, Wright AD, Carlone GM et al (2013) Immunoactivating peptide p4 augments alveolar macrophage phagocytosis in two diverse human populations. Antimicrob Agents Chemother 57:4566\u20134569","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Methods in Molecular Biology","Handbook of ELISPOT"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-8567-8_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T14:35:02Z","timestamp":1530196502000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-8567-8_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9781493985661","9781493985678"],"references-count":39,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-8567-8_18","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2018]]}}}